In addition, there are new drugs targeting epidermal growth factor receptor (EGFR) and mammalian target of rapamycin (mTOR) for the treatment of gliomas (Deluche et al., 2019; Heinzen et al., 2019; Hu et al., 2022). The gene discussed is EGFR; the disease is central nervous system cancer.